Skip to content

Landos Biopharma, Inc.: filings

Every Landos Biopharma, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 13 filings, each linked to its SEC index.

Filing record ends 2024-05-09

The latest filing in this captured record is a 10-Q filed 2024-05-09. No later filing is in the SEC companyfacts record captured on 2026-09-22. Landos Biopharma, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-05-09fiscal Q1 202431670000950170-24-056311
10-K2024-03-21fiscal FY 202337730000950170-24-034438
10-Q2023-11-09fiscal Q3 2023361060000950170-23-061560
10-Q2023-08-09fiscal Q2 2023361020000950170-23-040165
10-Q2023-05-12fiscal Q1 202336740000950170-23-021517
10-K2023-03-23fiscal FY 202239780000950170-23-009334
10-Q2022-11-10fiscal Q3 2022401160000950170-22-024194
10-Q2022-08-11fiscal Q2 2022391100000950170-22-016673
10-Q2022-05-12fiscal Q1 202235720000950170-22-009712
10-K2022-03-24fiscal FY 202133680000950170-22-004559
10-Q2021-11-15fiscal Q3 202132910000950170-21-004599
10-Q2021-07-29fiscal Q2 2021361030000950170-21-000583
10-Q2021-05-17fiscal Q1 202132660000950170-21-000248

Inspect the source

Entity
Landos Biopharma, Inc. / CIK 0001785345
Captured
SEC response SHA-256
4ec4696c9763958afa23f06dc7e5a8fc5411cbde06d1dc54f4b422903cb83a10

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001785345.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))